The HDAC Inhibitor, SAHA, Combined with Cisplatin Synergistically Induces Apoptosis in Alpha-fetoprotein-producing Hepatoid Adenocarcinoma Cells

Hepatoid adenocarcinoma (HAC) is a rare and aggressive gastrointestinal tract cancer that is characterized by hepatic differentiation and production of alpha-fetoprotein (AFP). Cisplatin is mainly used to treat HAC, but the efficacy is poor. Recently, the histone deacetylase inhibitor, suberoylanili...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Acta Histochem Cytochem
Auteurs principaux: Kyaw, Myat Tin Htwe, Yamaguchi, Yuya, Choijookhuu, Narantsog, Yano, Koichi, Takagi, Hideaki, Takahashi, Nobuyasu, Synn Oo, Phyu, Sato, Katsuaki, Hishikawa, Yoshitaka
Format: Artigo
Langue:Inglês
Publié: JAPAN SOCIETY OF HISTOCHEMISTRY AND CYTOCHEMISTRY 2019
Sujets:
Regular Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6434315/
https://ncbi.nlm.nih.gov/pubmed/30923410
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1267/ahc.18044
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires